Chembio Diagnostics and its subsidiaries develop, manufacture, and commercialize point-of-care diagnostic tests that are used to detect and diagnose diseases. The company's product commercialization and product development activities are focused on infectious disease testing and technology collaborations. In infectious disease, the company is commercializing tests for human immunodeficiency virus and Syphilis, Zika virus, and developing tests for malaria, dengue virus, chikungunya virus, ebola, lassa, Marburg, leptospirosis, Rickettsia typhi, Burkholderia pseudomallei, and Orientia tsutsugamushi, individually or as part of fever panel tests.

Domo provides a platform that digitally connects people, data and systems in an organization, giving them access to real-time data and insights and allowing them to manage their business from their smartphones. The company's platform provides access to data through a set of connection options, including connectors. The company's data warehouse, Adrenaline, stores data from across the business. Fusion is the company's data transformation engine that sorts customer data. The company's Explorer analytics suite allows users to analyze, display, share and interact with data through visualizations. With the Domo Appstore, APIs and developer tool kits, the company enables an ecosystem of partners to build applications on the platform.

RumbleON is a development stage company. The company is engaged in developing a capital light e-commerce platform facilitating the ability of both consumers and dealers to Buy-Sell-Trade-Finance pre-owned recreation vehicles in one online location. Serving both consumers and dealers, through its online marketplace platform, the company makes cash offers for the purchase of pre-owned vehicles. In addition, the company provides an inventory of pre-owned vehicles for sale along with third-party financing and associated products. The company utilizes regional partners in the acquisition of pre-owned vehicles to provide inspection, reconditioning and distribution services.

Safeguard Scientifics provides capital and relevant services for the growth of businesses in healthcare, financial services and digital media. The company's existing group of partner companies consist principally of technology-driven businesses in healthcare, financial services and digital media that are capitalizing on the enabling technologies, including enhanced security and predictive analytics. The company typically deploys up to $25 million in a company.